Sciele Pharma (SCRX) and Addrenex Pharmaceuticals Announce Analysis of Phase III Clinical Study of Clonicel® for Treatment of ADHD
Sciele Pharma (SCRX), based in Atlanta, Georgia, is a pharmaceutical company founded in 1992. The company specializes in sales, marketing and development of branded prescription products focused on the therapeutic areas of cardiovascular, diabetes, women’s health and pediatrics. Through its focus areas, the company’s products treat health issues such as hypertension, high cholesterol, and Type 2 diabetes. The company and Addrenex Pharmaceuticals recently announced that the preliminary analysis of the Phase III clinical study investigating the use of Clonicel® for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) showed statistically significant improvement over placebo. Addrenex Pharmaceuticals is a specialty pharmaceutical…